ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Clin Pharmacol Biopharm; 2021, Vol 10(8): e-120
  • DOI: 10.4172/2167-065X.1000e120

Assessment of new tablet formulation of deferasirox to decrease persistent iron overload after long-term blood transfusions

Xiaoya Zhang*
Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, USA
*Corresponding Author : Xiaoya Zhang, Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, USA, Email: xiaozha@gmail.com

Received Date: Aug 16, 2021 / Accepted Date: Aug 23, 2021 / Published Date: Aug 30, 2021

Citation: Zhang X (2021) Assessment of New Tablet Formulation of Deferasirox to Decrease Persistent Iron Overload after Long-Term Blood Transfusions. Clin Pharmacol Biopharm, 10: e120. Doi: 10.4172/2167-065X.1000e120

Copyright: © 2021 Zhang X. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top